Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China
Xiaoqi Pan, Lan Dong, Lian Yang, Dayi Chen, Cheng Yun Peng
Abstract
Xiaoqi Pan, Lan Dong, Lian Yang, Dayi Chen, Cheng Yun Peng
Abstract
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 69 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Coronavirus disease 2019 (COVID-19), Pneumonia, China, Government (linguistics), Coronavirus, Clinical trial, Intensive care medicine, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)